Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-14-008355
Filing Date
2014-11-17
Accepted
2014-11-17 17:26:27
Documents
3
Period of Report
2014-12-18
Effectiveness Date
2014-11-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENTS def14a1114_relmada.htm DEF 14A 527338
2 GRAPHIC img1.jpg GRAPHIC 13544
3 GRAPHIC img2.jpg GRAPHIC 7865
  Complete submission text file 0001213900-14-008355.txt   558221
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 333-184881 | Film No.: 141228836
SIC: 2834 Pharmaceutical Preparations